시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
일차 세포 시장 규모, 점유율, 성장 분석 : 유형별, 유래별, 용도별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)
Primary Cells Market Size, Share, Growth Analysis, By Type (Hematopoietic Cells), By Origin (Human Primary Cells, Animal Primary Cells), By Application, By End Use, By Region - Industry Forecast 2024-2031
상품코드 : 1619250
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,753,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,070,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,387,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 일차 세포 시장 규모는 2022년에 12억 3,000만 달러로 평가되며, 2023년 13억 6,000만 달러에서 2031년에는 30억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 10.4%로 성장할 전망입니다.

세계의 일차 세포 시장은 세포 기반의 연구에 대한 수요 증가와 만성질환의 유병률 증가에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 연구자들이 질병의 유전적, 분자적 배경을 더 깊이 파고들면서 환자 개개인의 특성에 맞는 표적 치료법을 개발하기 위해 1차 세포에 대한 수요가 급증하고 있습니다. 이러한 개별화 접근법은 질병 모델링과 약물 스크리닝에 대한 1차세포의 활용도를 높여 시장 확대를 더욱 가속화하고 있습니다. 암, 심혈관 질환, 신경계 질환 등 만성질환의 확산으로 질병 기전 연구와 혁신적 치료제 시험에 필수적인 세포에 대한 수요가 증가하고 있습니다. 조직의 복잡한 생리적 환경을 충실하게 재현할 수 있는 1차세포는 질병의 병태생리를 이해하고 효과적인 치료법을 고안하는 데 필수적입니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

일차 세포 시장 규모 : 유형별 & CAGR(2024-2031)

일차 세포 시장 규모 : 유래 별 & CAGR(2024-2031)

일차 세포 시장 규모 : 용도별 & CAGR(2024-2031)

일차 세포 시장 규모 : 최종 용도별 & CAGR(2024-2031)

일차 세포 시장 규모 : 지역별 & CAGR(2024-2031)

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Primary Cells Market size was valued at USD 1.23 billion in 2022 and is poised to grow from USD 1.36 billion in 2023 to USD 3.0 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The global primary cells market is witnessing significant growth propelled by heightened demand for cell-based research and the growing incidence of chronic diseases. As researchers delve deeper into the genetic and molecular underpinnings of conditions, the need for primary cells has surged, allowing for the development of targeted therapies suited to individual patient profiles. This personalized approach has intensified the use of primary cells in disease modeling and drug screening, further stimulating market expansion. The prevalence of chronic diseases, including cancer, cardiovascular, and neurological disorders, has amplified the requirement for these cells, essential for studying disease mechanisms and testing innovative therapeutics. Their capacity to closely replicate the complex physiological environments of tissues makes primary cells critical for comprehending disease pathology and crafting effective interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Primary Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Primary Cells Market Segmental Analysis

Global Primary Cells Market is segmented by type, origin, application, end use and region. Based on type, the market is segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, renal cells and other cells. Based on origin, the market is segmented into human primary cells and animal primary cells. Based on application, the market is segmented into research applications and therapeutic applications. Based on end use, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and cell banks and tissue banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Primary Cells Market

The Global Primary Cells market is experiencing robust growth, primarily fueled by recent advancements in Tissue Engineering and Regenerative Medicine. These innovations have elevated the importance of primary cells in creating engineered tissues and organs intended for transplantation. As the medical community increasingly prioritizes regenerative medicine for its potential to address various health issues, the demand for primary cells has surged. This heightened emphasis on tissue engineering not only enhances the capabilities of medical treatments but also significantly contributes to the overall expansion of the primary cells market, reflecting a promising outlook for future developments in healthcare.

Restraints in the Global Primary Cells Market

The global primary cells market is hindered by the inherent limitation of a short shelf life when compared to immortalized cell lines. As primary cells age, they tend to undergo senescence and may gradually lose their unique characteristics, ultimately resulting in diminished functionality. This reduced lifespan creates significant challenges for storage, transportation, and utilization in extended experimental protocols, which can adversely affect their overall market potential. Consequently, researchers and manufacturers must contend with these limitations, impacting the broader adoption and use of primary cells in various applications and hindering growth within the market.

Market Trends of the Global Primary Cells Market

The Global Primary Cells market is experiencing significant growth driven by the rising demand for personalised medicine. This innovative approach emphasizes tailoring medical treatments to individual patients by leveraging their unique genetic profiles and disease characteristics. Primary cells offer a more authentic representation of human biology, making them essential for researchers and pharmaceutical companies focused on developing targeted therapies and conducting preclinical studies. Their ability to facilitate patient-specific response evaluations enhances drug efficacy and safety assessments, thereby accelerating the adoption of primary cells in drug discovery and development. This trend positions the Global Primary Cells market as a vital component of advancing personalized healthcare solutions.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Primary Cells Market Size by By Type & CAGR (2024-2031)

Global Primary Cells Market Size by Origin & CAGR (2024-2031)

Global Primary Cells Market Size by Application & CAGR (2024-2031)

Global Primary Cells Market Size by End Use & CAGR (2024-2031)

Global Primary Cells Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기